+Search query
-Structure paper
Title | A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 59, Page 132-146, Year 2016 |
Publish date | Nov 20, 2015 (structure data deposition date) |
Authors | Bold, G. / Schnell, C. / Furet, P. / McSheehy, P. / Bruggen, J. / Mestan, J. / Manley, P.W. / Druckes, P. / Burglin, M. / Durler, U. ...Bold, G. / Schnell, C. / Furet, P. / McSheehy, P. / Bruggen, J. / Mestan, J. / Manley, P.W. / Druckes, P. / Burglin, M. / Durler, U. / Loretan, J. / Reuter, R. / Wartmann, M. / Theuer, A. / Bauer-Probst, B. / Martiny-Baron, G. / Allegrini, P. / Goepfert, A. / Wood, J. / Littlewood-Evans, A. |
External links | J. Med. Chem. / PubMed:26629594 |
Methods | X-ray diffraction |
Resolution | 2.5 Å |
Structure data | PDB-5ew3: |
Chemicals | ChemComp-5T2: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE / kdr / kinase domain / ATP-binding site / VEGFR2 inhibitors |